Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;51(5):407-415.
doi: 10.5946/ce.2018.140. Epub 2018 Sep 27.

Various Intragastric Balloons Under Clinical Investigation

Seong Ji Choi  1 , Hyuk Soon Choi  1
Affiliations

Various Intragastric Balloons Under Clinical Investigation

Seong Ji Choi et al. Clin Endosc. 2018 Sep.

Abstract

Obesity is a chronic disease with an exponentially increasing incidence rate, and its negative effects are well documented in numerous studies. As a result, the importance of bariatric therapy cannot be overemphasized, and many bariatric treatment methods with varying mechanisms have been developed. Of the available treatment methods, intragastric balloons, introduced in the 1980s, have been shown to be a safe and effective treatment modality; various intragastric balloon products have been developed and are currently being widely used in clinical settings. However, the disadvantages of intragastric balloons, such as unclear long-term weight loss benefits and complications experienced during insertion and removal, preclude their wider use. In this review, we discuss different intragastric balloon products, focusing on those under clinical investigation, and suggest future research directions.

Keywords: Bariatrics; Endoscopy; Intragastric balloons; Obesity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:The authors have no financial conflicts of interest.

Figures

Fig. 1.
Fig. 1.
(A) Spatz3 Balloon [28]. (B) ElipseTM Balloon [31]. (C) Heliosphere Bag [34].
Fig. 2.
Fig. 2.
(A) Medsil® [39]. (B) LexBal (http://www.lexelmedical.com). (C) End-Ball (http://www.endalis.com).
Fig. 3.
Fig. 3.
(A) Adjustable Totally Implantable Intragastric Prosthesis-Endogast® (http://districlass.com). (B) Silimed Gastric Balloon [21]. (C) Semistationary Antral Balloon [22]. (D) Medicone® (https://www.medicone.com.br).
See this image and copyright information in PMC

References

    1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–781. - PMC - PubMed
    1. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014;26:20–24. - PMC - PubMed
    1. Grand View Research . San Francisco (CA): Grand View Research; c2016. Obesity treatment market size & forecast, by drugs (combination drugs, appetite suppressants, malabsorption & satiety drugs), by surgery & devices (adjustable gastric banding, Rouxen-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures) and trend analysis to 2024 [Internet] [updated 2016 Sep; cited 2018 Sep 20]. Available from: https://www.grandviewresearch.com/industry-analysis/obesity-treatment-de....
    1. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20:377–388. - PMC - PubMed
    1. Nguyen NT, Vu S, Kim E, Bodunova N, Phelan MJ. Trends in utilization of bariatric surgery, 2009-2012. Surg Endosc. 2016;30:2723–2727. - PubMed

LinkOut - more resources